Question Bank › The product is disappearing into reorder rhythm

The product is disappearing into reorder rhythm

The product is disappearing into reorder rhythm: revenue is shifting from won-each-time to arriving-on-its-own, and the

Calls Tested
500
Answered YES
5
Hit Rate
1%
rare by design

Amgen Inc. (AMGN) — this company's answers

NO on the Q3 2018 call 2018-10-30 B+
The model's full reasoning — Q3 2018 call → NOWe need answer YES or NO based on transcript. Need determine if management describes growing share of revenue arrives without new selling event through reorders/refills/renewals etc, and that this self-arriving share has recently and visibly grown as proportion, grounded in observed current behavior. We need parse transcript. Company Amgen. Products: Prolia, Repatha, Aimovig, etc. Need find any mention of recurring revenue, repeat purchases, refills, etc. Look for relevant statements. Murdo Gordon on Prolia: "Repeat injection rates in the U.S. remain especially strong at over 70% if you recall we do see some seasonality with Prolia demand which held true in the third quarter this year." That is repeat injection rates. Is that self-arriving revenue? Prolia is injectable twice yearly? Repeat injection rates over 70% means patients come back for next dose. But is that described as growing share of revenue? It says "remain especially strong" not recently grown. Also "we do see some seasonality" not proportion shift. Aimovig: patients starting, prescriptions. Not repeat. Repatha: access, volume growth. Biosimilars: launches. Need find if management describes that a growing share of revenue now arrives without new selling event. Maybe "repeat injection rates" is a repeat mechanism. But does management convey proportion has recently moved? No, says remain strong. Also "repeat injection rates" is not necessarily revenue without selling event? It is patient adherence, but still requires prescription refill. Could be considered self-arriving? But no recent growth. Maybe "Onpro continues to represent a majority of Neulasta sales" - that's delivery device, not recurring. Maybe "installed base" for Aimovig? No. Question asks: "Using ONLY supplied earnings call transcript... On this call, does management describe that a GROWING SHARE OF THE COMPANY'S REVENUE NOW ARRIVES WITHOUT A NEW SELLING EVENT — through reorders, refills, renewals, repeat purchases, usage-driven billing, aftermarket or consumable pull-through, or customers' own standing routines — AND that this self-arriving share has RECENTLY AND VISIBLY GROWN as a proportion of the business, with management grounding the shift in observed current behavior and treating it as changing the company's quality of revenue?" Need answer YES only if both halves present.

← Back to the full AMGN analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management describe that a GROWING SHARE OF THE COMPANY'S REVENUE NOW ARRIVES WITHOUT A NEW SELLING EVENT — through reorders, refills, renewals, repeat purchases, usage-driven billing, aftermarket or consumable pull-through, or customers' own standing routines — AND that this self-arriving share has RECENTLY AND VISIBLY GROWN as a proportion of the business, with management grounding the shift in observed current behavior and treating it as changing the company's quality of revenue? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent recent shift with both halves present: (1) SELF-ARRIVING REVENUE, OBSERVED NOW: management points to real, current repeat-mechanism revenue — reorder rates, renewal behavior, consumable or aftermarket attach, usage growth from installed product, or customers reordering on their own schedule — described with concrete grounding in the recent period, not asserted through generic 'recurring revenue' or 'loyal customers' language; and (2) THE PROPORTION HAS RECENTLY MOVED: management conveys that this self-arriving component is a visibly LARGER share of the business than it recently was — through an installed base that has recently scaled, a consumable or service stream now compounding on top of equipment already placed, or repeat behavior recently strengthening — so the company's revenue is becoming progressively less dependent on winning each sale, with the mix still early in its shift. Answer NO if the business has always been overwhelmingly recurring or contractual with nothing recently shifted. NO if repeat language is boilerplate with no observed behavior or recent change. NO if the repeat revenue is forced by contract lock-in with no customer choice described. NO if the shift is only planned or hoped for. NO if the pattern rests on one anecdote, or appears only in an analyst's question management does not affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
DUOT Duos Technologies Group, Inc. Q4 2023 2024-04-01 F
QTRX Quanterix Corporation Q3 2023 2023-11-07 B
CYBR CyberArk Software Ltd. Q3 2021 2021-11-04 B+
IRBT iRobot Corporation Q3 2021 2021-10-28 D
TOUR Tuniu Corporation Q4 2017 2018-03-14 D

How the model reasoned

DUOT · Q4 2023 → YESThe question is about whether management describes a growing share of revenue arriving without a new selling event, through reorders, renewals, etc., and that this has recently and visibly grown as a ...
QTRX · Q3 2023 → YESThe question is about whether management describes a growing share of revenue arriving without a new selling event, like through reorders, consumables, etc., and that this share has recently grown.
CYBR · Q3 2021 → YESThe question is about whether management describes a growing share of revenue arriving without a new selling event, like through renewals, and that this has recently grown as a proportion.

More from the question bank

Named catch-up gapWorking for customers it could not have servPaid to expand: the company's growth spendinVolume records through a still-fixed gateRecently unlocked doorSelling something whose payoff to the buyer All questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.